Fabry disease trials in Slovenia

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients

  Where

  Slovenj Gradec

  Age

  18 years and over

  People

  100 worldwide

  Run by

  Chiesi Farmaceutici S.p.A.

  See details and how to joinNCT06663358